ADVANCED HEART FAILURE

This study tests whether a mechanical heart pump (HeartMate 3) can help people with advanced heart failure live longer and avoid serious complications like stroke or the need for a heart transplant. About 850 participants will either receive the pump or continue standard medical …

This study tests a new device called the Icoms FlowMaker, designed to help the heart pump more blood in people with severe heart failure. Ten patients who are too sick for standard treatments will receive the implant. The main goal is to see if the device is safe and works well f…

This Phase 3 trial tests whether injecting lab-grown heart muscle cells (HiCM-188) into the heart during bypass surgery can help people with severe heart failure (NYHA class III-IV). Eighty participants will receive either the stem cells plus bypass or bypass alone. The main goal…

This study looks at 128 people with advanced heart failure who have a HeartMate3 heart pump. All take warfarin to prevent clots, and half will also stop taking aspirin. The goal is to see if skipping aspirin lowers the risk of serious bleeding without raising the chance of danger…

This study tests a new heart pump (CorWave LVAS) in 20 people with advanced heart failure. The pump helps the heart pump blood when it is too weak. The goal is to see if the device is safe and works well, with a focus on survival and avoiding serious problems like bleeding, infec…

This early-phase trial tests whether sildenafil (the drug in Viagra) can reduce blood vessel damage in people with advanced heart failure who have a mechanical heart pump (LVAD). LVADs help patients live longer, but they often cause blood vessel aging that leads to strokes or ble…

This study looks at 200 people with heart failure who are getting a left ventricular assist device (LVAD), a type of heart pump. Researchers will use a special 3D ultrasound during surgery to take detailed pictures of the right side of the heart. The goal is to better understand …

This study is observing 400 adults with advanced heart failure who have received a continuous-flow ventricular assist device (VAD), a mechanical pump that helps the heart circulate blood. Researchers will track survival rates in the hospital and at one and five years after implan…

This study is for adults with advanced heart failure who are getting a mechanical heart pump (LVAD). Researchers want to see if a substance in the blood called GDF-15 can help predict early complications or death after surgery. The goal is to better identify high-risk patients be…

This study looks at data from the HeartMate 3 heart pump to see if it can help predict problems like bleeding, infection, or frailty in people with advanced heart failure. Researchers will track 150 adults getting the pump and compare pump alarms and readings to their health over…

This study is testing whether a special nutrition shake (Ensure Surgery Immunonutrition) can improve gut health and reduce inflammation in heart failure patients awaiting LVAD surgery. Researchers will give the shake to 50 hospitalized patients before their operation and track ch…

This study tests a tool designed to help people with advanced heart failure understand what life is like after getting a ventricular assist device (VAD), a mechanical heart pump. Researchers created the tool based on surveys from previous VAD patients about their quality of life …

This study follows 103 advanced heart failure patients on a transplant waiting list to see how dapagliflozin affects the link between heart and kidney health. Researchers will measure a protein called suPAR in the blood over 6 months to track kidney damage. The goal is to better …